← Open Payments lookup

DANIEL KELLEHER: Open Payments

NPI 1740278589 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,556 in 66 payments from 14 companies in 2025. Trend: 2023 $1,602 · 2024 $1,305 · 2025 $1,556

Food & beverage: $1,556
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.11$314
ABBVIE INC.14$278
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$231
Supernus Pharmaceuticals, Inc.7$172
Neurocrine BioSciences, Inc.5$138
Otsuka America Pharmaceutical, Inc.4$79
Teva Pharmaceuticals USA, Inc.3$67
Vertical Pharmaceuticals, LLC4$66
Corium, LLC2$61
E.R. Squibb & Sons, L.L.C.2$55

Products named: FANAPT, VRAYLAR, CAPLYTA, Qelbree, INGREZZA, REXULTI, AUSTEDO XR, Relexxii.

Industry payments across CT — which companies pay providers there.